Tecsys Inc. (TSX:TCS)

Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	584	629	579	373	380	654
Market Cap Growth	8.71%	8.71%	55.25%	-1.94%	-41.92%	95.26%
Enterprise Value	546	598	548	350	360	634
Last Close Price	39.37	42.29	38.35	25.07	25.32	43.50
PE Ratio	131.23	141.06	312.93	178.41	84.88	91.05
Forward PE	84.67	74.03	84.22	64.48	81.56	90.24
PS Ratio	3.31	3.57	3.38	2.44	2.77	5.32
PB Ratio	8.19	8.83	8.46	5.29	5.53	9.76
P/TBV Ratio	13.62	14.67	14.24	9.00	9.59	17.98
P/FCF Ratio	44.63	48.09	135.95	49.65	90.26	36.06
P/OCF Ratio	41.97	45.22	119.18	44.60	76.88	34.24
EV/Sales Ratio	3.09	3.39	3.20	2.30	2.63	5.15
EV/EBITDA Ratio	59.78	68.73	95.67	65.15	48.53	50.21
EV/EBIT Ratio	76.01	83.27	135.07	98.20	67.03	59.38
EV/FCF Ratio	41.73	45.71	128.69	46.68	85.58	34.94
Debt / Equity Ratio	0.02	0.02	0.03	0.04	0.21	0.28
Debt / EBITDA Ratio	0.14	0.14	0.34	0.48	1.73	1.38
Debt / FCF Ratio	0.10	0.10	0.50	0.39	3.38	1.03
Asset Turnover	1.32	1.32	1.34	1.21	1.08	0.97
Inventory Turnover	58.02	58.02	79.76	96.36	110.80	102.91
Quick Ratio	1.14	1.14	1.20	1.27	1.55	1.60
Current Ratio	1.32	1.32	1.38	1.45	1.71	1.72
Return on Equity (ROE)	6.39%	6.39%	2.66%	3.00%	6.60%	11.21%
Return on Assets (ROA)	3.34%	3.34%	1.99%	1.76%	2.63%	5.26%
Return on Capital (ROIC)	6.27%	6.27%	3.52%	2.85%	3.98%	7.95%
Return on Capital Employed (ROCE)	9.90%	9.90%	5.70%	4.80%	6.50%	12.50%
Earnings Yield	0.76%	0.71%	0.32%	0.56%	1.18%	1.10%
FCF Yield	2.24%	2.08%	0.74%	2.01%	1.11%	2.77%
Dividend Yield	0.86%	0.78%	0.81%	1.16%	1.07%	0.57%
Payout Ratio	109.44%	109.44%	246.62%	202.25%	87.74%	50.18%
Buyback Yield / Dilution	-1.03%	-1.03%	0.55%	0.70%	-0.88%	-12.84%
Total Shareholder Return	-0.16%	-0.25%	1.35%	1.86%	0.18%	-12.26%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.